Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06538012
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more
Essen Biotech 85
Very early researchUnknownNCT06067581
What this trial is testing

The Safety and Efficacy of SENL103 Autologous T Cell Injection

Who this might be right for
Multiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 20
Large-scale testing (Phase 3)UnknownNCT02531841
What this trial is testing

High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphoma
University Hospital Freiburg 250
Early research (Phase 1)Active Not RecruitingNCT03017131
What this trial is testing

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729
What this trial is testing

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Looking for participantsNCT06687772
What this trial is testing

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404595
What this trial is testing

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

Who this might be right for
Gastric CancerPancreatic Cancer
CARsgen Therapeutics Co., Ltd. 110
Early research (Phase 1)Study completedNCT02401295
What this trial is testing

ATRA, Celecoxib, and Itraconazole as Maintenance

Who this might be right for
Relapsed Multiple Myeloma
University of Iowa 1
Early research (Phase 1)UnknownNCT03029273
What this trial is testing

NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell, Recurrent
Guangzhou Institute of Respiratory Disease 20
Early research (Phase 1)Ended earlyNCT02716805
What this trial is testing

Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Ludwig Institute for Cancer Research 6
Not applicableNot Yet RecruitingNCT07362394
What this trial is testing

Autologous Dentine Graft Compared to Xenograft in Managing Periodontally Compromised Second Molar After Third Molar Removal

Who this might be right for
Impacted Mandibular Third Molar ExtractionDentin GraftXenograft+1 more
National University of Malaysia 34
Large-scale testing (Phase 3)Study completedNCT00207805
What this trial is testing

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre National de Greffe de Moelle Osseuse 202
Not applicableNo Longer AvailableNCT04465929
What this trial is testing

Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair

Who this might be right for
Peripheral Nerve Injuries
W. Dalton Dietrich
Not applicableUnknownNCT05294822
What this trial is testing

Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

Who this might be right for
Diabetes
Shanghai Changzheng Hospital 20
Not applicableWithdrawnNCT06377202
What this trial is testing

Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies

Who this might be right for
Cancer
Verismo Therapeutics
Very early researchUnknownNCT03205670
What this trial is testing

Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers

Who this might be right for
Urethral Stricture
I.M. Sechenov First Moscow State Medical University 6
Early research (Phase 1)WithdrawnNCT01343394
What this trial is testing

Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children

Who this might be right for
Hearing Loss
Aryn Knight
Testing effectiveness (Phase 2)WithdrawnNCT01072370
What this trial is testing

Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children

Who this might be right for
Cerebral Palsy
Augusta University
Early research (Phase 1)Ended earlyNCT02588456
What this trial is testing

Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
University of Pennsylvania 5
Testing effectiveness (Phase 2)Ended earlyNCT00792831
What this trial is testing

Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Italfarmaco 3
Next Page